The ICOMS works either in a systole-synchronized or a continuous mode. In synchronous mode, the device works as an adjunct to the natural heart function and augments cardiac output to optimized levels. For patients with significant ventricular arrhythmias, the device can work in continuous mode to fully carry output requirements. Synchronous (pulsatile) mode is considered to be the primary mode of operation.
The surgical technique is very similar to the one used for Transcatheter Aortic Valve Implantation (TAVI) that is familiar to most cardiothoracic surgeons. It is implanted in a beating heart via a mini-left thoracotomy and anchored in the apex of the left ventricle through a proprietary dedicated delivery system.
Contrary to others LVAD, there is no bypass of the heart, allowing a mini-surgical approach on a beating heart and the preservation of the innate heart contraction. Described as an electrical bicycle of the heart, the ICOMS will propel blood towards the aortic valve and will support the native cardiac contraction by accelerating the blood at every beat. The device is also powered due to a Transcutaneous Energy Transfer (TET) system which allows a wireless communication and therefore, no percutaneous drivelines.
The ICOMS system is synchronized to heart innate contraction. Its unique technology between a Pacemaker and a LVAD offers a new way to manage heart failure disease.
Major benefits of the ICOMS are the following:
Synchronized to heart innate contraction.
No wire coming out of the body, reducing the risk of severe infections and bringing back a high level of quality of life to the patient.
Includes a dedicated programmer to allow fine tuning to specific patient requirements.
Thoracotomy with only two small incisions and no need of using extracorporeal circulation.